Conduit Pharmaceuticals Inc (NASDAQ:CDT) has a beta value of 2.29 and has seen 24.98 million shares traded in the last trading session. The CDT stock price is -7457.14% off its 52-week high price of $5.29 and 28.57% above the 52-week low of $0.05. If we look at the company’s 10-day average daily trading volume, we find that it stood at 15.92 million shares traded. The 3-month trading volume is 27.03 million shares.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Sporting 1.54% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CDT stock price touched $0.07 or saw a rise of 19.72%. Year-to-date, Conduit Pharmaceuticals Inc shares have moved 5.39%, while the 5-day performance has seen it change 20.30%. Over the past 30 days, the shares of Conduit Pharmaceuticals Inc (NASDAQ:CDT) have changed -25.00%. Short interest in the company has seen 3.57 million shares shorted with days to cover at 0.14.

Conduit Pharmaceuticals Inc (CDT) estimates and forecasts

The company’s shares have lost -85.54% over the past 6 months.

CDT Dividends

Conduit Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

Insiders own 49.12% of the company shares, while shares held by institutions stand at 4.06% with a share float percentage of 7.97%. Investors are also buoyed by the number of investors in a company, with Conduit Pharmaceuticals Inc having a total of 52.0 institutions that hold shares in the company.